IL130251A0 - Heterocyclic carboxylic acid derivatives the production and use thereof as endothelin receptor antagonists - Google Patents
Heterocyclic carboxylic acid derivatives the production and use thereof as endothelin receptor antagonistsInfo
- Publication number
- IL130251A0 IL130251A0 IL13025197A IL13025197A IL130251A0 IL 130251 A0 IL130251 A0 IL 130251A0 IL 13025197 A IL13025197 A IL 13025197A IL 13025197 A IL13025197 A IL 13025197A IL 130251 A0 IL130251 A0 IL 130251A0
- Authority
- IL
- Israel
- Prior art keywords
- production
- carboxylic acid
- acid derivatives
- receptor antagonists
- endothelin receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
- C07D237/16—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
- C07D253/10—Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1996152763 DE19652763A1 (de) | 1996-12-18 | 1996-12-18 | Heterozyklische Carbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
DE1997100884 DE19700884A1 (de) | 1997-01-13 | 1997-01-13 | Heterozyklische Carbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
PCT/EP1997/006778 WO1998027070A1 (de) | 1996-12-18 | 1997-12-04 | Heterozyklische carbonsäurederivate, ihre herstellung und verwendung als endothelinrezeptorantagonisten |
Publications (1)
Publication Number | Publication Date |
---|---|
IL130251A0 true IL130251A0 (en) | 2000-06-01 |
Family
ID=26032394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13025197A IL130251A0 (en) | 1996-12-18 | 1997-12-04 | Heterocyclic carboxylic acid derivatives the production and use thereof as endothelin receptor antagonists |
Country Status (21)
Country | Link |
---|---|
US (1) | US6448248B1 (xx) |
EP (1) | EP0946524A1 (xx) |
JP (1) | JP2001506243A (xx) |
KR (1) | KR20000057642A (xx) |
CN (1) | CN1247533A (xx) |
AR (1) | AR010359A1 (xx) |
AU (1) | AU740351B2 (xx) |
BG (1) | BG103502A (xx) |
BR (1) | BR9714047A (xx) |
CA (1) | CA2275256A1 (xx) |
CO (1) | CO4930270A1 (xx) |
HR (1) | HRP970686A2 (xx) |
HU (1) | HUP0000553A3 (xx) |
ID (1) | ID26234A (xx) |
IL (1) | IL130251A0 (xx) |
NO (1) | NO313519B1 (xx) |
NZ (1) | NZ336157A (xx) |
PL (1) | PL334014A1 (xx) |
SK (1) | SK77799A3 (xx) |
TR (1) | TR199901416T2 (xx) |
WO (1) | WO1998027070A1 (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6329384B1 (en) * | 1997-09-26 | 2001-12-11 | Abbott Laboratories | Endothelin antagonist and renin-angiotensin system inhibitor as a combined preparation |
DE19743143A1 (de) * | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
DE69830069T3 (de) * | 1997-10-17 | 2012-02-09 | Ark Therapeutics Ltd. | Verwendung von hemmern des renin-angiotensin systems zur behandlung von hypoxie oder verringertem stoffwechsel |
DE19806438A1 (de) * | 1998-02-17 | 1999-08-19 | Basf Ag | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
DE19858779A1 (de) * | 1998-12-18 | 2000-06-21 | Basf Ag | Neue ß-Amido und ß-Sulfonamidocarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
DE19924892A1 (de) * | 1999-06-01 | 2000-12-07 | Basf Ag | Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
MXPA02003419A (es) * | 1999-10-06 | 2002-10-17 | Basf Ag | Moduladores de las vias de senalizacion mediadas por citocina y antagonistas de los receptores para integrina alfav°3 para tratamiento en combinacion. |
FI20010233A0 (fi) | 2001-02-08 | 2001-02-08 | Orion Corp | Menetelmä sydämen vajaatoiminnan hoitoon |
WO2003006041A1 (fr) * | 2001-07-12 | 2003-01-23 | Takeda Chemical Industries, Ltd. | Agents prophylactiques/therapeutiques contre les tumeurs malignes |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2671551B1 (fr) * | 1991-01-15 | 1993-03-12 | Adir | Nouveaux composes de structure aryl triazinique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
DE19533023B4 (de) | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
DE19614534A1 (de) | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
DE19614533A1 (de) | 1996-04-12 | 1997-10-16 | Basf Ag | Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung |
DE19614542A1 (de) | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
-
1997
- 1997-12-04 US US09/319,876 patent/US6448248B1/en not_active Expired - Fee Related
- 1997-12-04 KR KR1019990705445A patent/KR20000057642A/ko not_active Application Discontinuation
- 1997-12-04 AU AU56594/98A patent/AU740351B2/en not_active Ceased
- 1997-12-04 IL IL13025197A patent/IL130251A0/xx unknown
- 1997-12-04 CN CN97181869A patent/CN1247533A/zh active Pending
- 1997-12-04 WO PCT/EP1997/006778 patent/WO1998027070A1/de not_active Application Discontinuation
- 1997-12-04 HU HU0000553A patent/HUP0000553A3/hu unknown
- 1997-12-04 NZ NZ336157A patent/NZ336157A/xx unknown
- 1997-12-04 PL PL97334014A patent/PL334014A1/xx unknown
- 1997-12-04 JP JP52724798A patent/JP2001506243A/ja active Pending
- 1997-12-04 EP EP97952876A patent/EP0946524A1/de not_active Withdrawn
- 1997-12-04 TR TR1999/01416T patent/TR199901416T2/xx unknown
- 1997-12-04 SK SK777-99A patent/SK77799A3/sk unknown
- 1997-12-04 BR BR9714047-3A patent/BR9714047A/pt not_active IP Right Cessation
- 1997-12-04 ID IDW990558A patent/ID26234A/id unknown
- 1997-12-04 CA CA002275256A patent/CA2275256A1/en not_active Abandoned
- 1997-12-16 HR HR19700884.4A patent/HRP970686A2/hr not_active Application Discontinuation
- 1997-12-16 AR ARP970105907A patent/AR010359A1/es not_active Application Discontinuation
- 1997-12-17 CO CO97073662A patent/CO4930270A1/es unknown
-
1999
- 1999-06-17 NO NO19992976A patent/NO313519B1/no not_active IP Right Cessation
- 1999-06-18 BG BG103502A patent/BG103502A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CO4930270A1 (es) | 2000-06-27 |
KR20000057642A (ko) | 2000-09-25 |
NO992976D0 (no) | 1999-06-17 |
NO313519B1 (no) | 2002-10-14 |
NZ336157A (en) | 2000-10-27 |
CA2275256A1 (en) | 1998-06-25 |
SK77799A3 (en) | 2000-02-14 |
US6448248B1 (en) | 2002-09-10 |
BG103502A (en) | 2000-07-31 |
EP0946524A1 (de) | 1999-10-06 |
HRP970686A2 (en) | 1998-10-31 |
WO1998027070A1 (de) | 1998-06-25 |
BR9714047A (pt) | 2000-05-09 |
ID26234A (id) | 2000-12-07 |
PL334014A1 (en) | 2000-01-31 |
AU5659498A (en) | 1998-07-15 |
TR199901416T2 (xx) | 1999-08-23 |
CN1247533A (zh) | 2000-03-15 |
JP2001506243A (ja) | 2001-05-15 |
HUP0000553A3 (en) | 2001-08-28 |
NO992976L (no) | 1999-06-17 |
AU740351B2 (en) | 2001-11-01 |
HUP0000553A1 (hu) | 2001-04-28 |
AR010359A1 (es) | 2000-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL122464A0 (en) | N-heteroaryl-pyridinesulonamide derivatives and their use as endothelin antagonists | |
HK1019149A1 (en) | Indole derivatives useful as endothelin receptor antagonists | |
PL350428A1 (en) | 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists | |
SI1035115T1 (en) | 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists | |
HUP0202202A3 (en) | Benzoxepino [2,3-b]pyridine derivatives and analogues as chemokine receptor antagonists and the use thereof | |
IL123581A0 (en) | Pyrimidine derivatives as 5HT2c- receptor antagonists | |
PL331998A1 (en) | Derivatives of azinyloxy-a nd phenyloxy-diaryl carboxylic acids, their production and application as mixed antagonists of endothelin et/et receptors | |
HUP0003484A3 (en) | Pyrrolidine-3-crboxylic acid derivatives and their use as endothelin antagonists | |
HRP970199A2 (en) | New carboxylic acid derivatives, their production and use | |
IL130251A0 (en) | Heterocyclic carboxylic acid derivatives the production and use thereof as endothelin receptor antagonists | |
HRP970200A2 (en) | Novel carboxylic acid derivatives, their production and use | |
IL135347A0 (en) | New carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists | |
IL133104A0 (en) | New - beta-amino and beta-azidocarboxylic acid derivatives the production thereof and the use thereof as endothelin receptor antagonists | |
NZ315846A (en) | Endothelin receptor antagonists, in particular, substituted pyrazol-4-yl-substituted-prop-2-enoic acid derivatives | |
PL348667A1 (en) | Pyrrolidine carboxylic acid derivatives as endothelin antagonists | |
IL134276A0 (en) | Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists | |
IL137038A0 (en) | 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists | |
IL143451A0 (en) | NEW- β-AMIDE AND β-SULFONAMIDE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS | |
ZA9711305B (en) | Heterocyclic carboxylic acid derivatives their preparation and use as endothelin receptor antagonists | |
IL132615A0 (en) | Pyrrolidine carboxylic acid derivatives as endothelin antagonists | |
IL147666A0 (en) | Novel carboxylic acid derivatives with 5, 6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists | |
HUP0102531A3 (en) | Carboxy substituted carboxamide derivatives and their use as tachykinin receptor antagonists | |
GR3033237T3 (en) | Quinoline derivatives as leukoriene antagonists. | |
HK1047102A1 (zh) | 新的具有芳香基取代的氮雜環的羧酸衍生物、其製備和作為內皮素受體拮抗劑的應用 | |
SI0832082T1 (en) | N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HP | Change in proprietorship |